CAAS Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-80,614
Closed -$1.86M 910
2020
Q3
$1.86M Buy
+80,614
New +$1.84M 0.04% 271

Other funds holding REPL

CAAS Capital Management's REPL Position: Q4 2020 in Review

CAAS Capital Management sold out of Replimune Group (REPL) in Q4 2020, closing a stake of 80,614 shares — an estimated $1.86M sold.

CAAS Capital Management first reported a position in REPL in Q3 2020 and held it in 1 quarter. The position peaked at $1.86M in Q3 2020. 112 funds tracked by Wall St. Rank hold REPL as of Q4 2020.

  • CAAS Capital Management reported no remaining Replimune Group position as of Q4 2020 after selling out during the quarter.
  • CAAS Capital Management sold 80,614 Replimune Group shares in Q4 2020, an estimated $1.86M.
  • CAAS Capital Management first reported a position in Replimune Group in Q3 2020 and held it in 1 quarter.
  • CAAS Capital Management's Replimune Group position peaked at $1.86M in Q3 2020.
  • 112 funds tracked by Wall St. Rank held Replimune Group as of Q4 2020.

Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.